Embracing Neurodiversity in Psychedelic Science: A Mixed-Methods Inquiry into the MDMA Experiences of Autistic Adults

References

• Baron-Cohen, S., S. Wheelwright, R. Skinner, J. Martin, and E. Clubley. 2001. The autism-spectrum quotient (AQ): Evidence from asperger syndrome/high-functioning autism, malesand females, scientists and mathematicians. Journal of Autism and Developmental Disorders 31 (1):5–17.
   PubMed Web of Science ®Google Scholar
• Bejerot, S., J. M. Eriksson, and E. Mörtberg. 2014. Social anxiety in adult autism spectrum disorder. Psychiatry Research 220 (1–2):705–07. doi:10.1016/j.psychres.2014.08.030.
   PubMed Web of Science ®Google Scholar
• Brooks, C. 2010. Embodied transcription: A creative method for using voice-recognition software. The Qualitative Report 15 (5):1227–42.
   Google Scholar
• Danforth, A. 2013. Courage, connection, clarity: A mixed-model, collective-case study of MDMA (ecstasy) experiences of autistic adults (Doctoral dissertation). Retrieved from ProQuest Dissertations & Theses (PQDT) database. (UMI No. 3596826)
   Google Scholar
• Danforth, A. L., C. M. Struble, B. Yazar-Klosinski, and C. S. Grob. 2016. MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64:237–49. doi:10.1016/j.pnpbp.2015.03.011.
   PubMed Web of Science ®Google Scholar
• Danforth, A. L., C. S. Grob, C. Struble, A. A. Feduccia, N. Walker, L. Jerome, B. Yazar-Klosinski, and A. Emerson. 2018. Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: A randomized, double-blind, placebo-controlled pilot study. Psychopharmacology 235 (11):3137–48. doi:10.1007/s00213-018-5010-9.
   PubMed Web of Science ®Google Scholar
• Davidson, J. 2008. Autistic culture online: Virtual communication and cultural expression on the spectrum. Social & Cultural Geography 9 (7):791–806. doi:10.1080/14649360802382586.
   Web of Science ®Google Scholar
• de Win, M. M., L. Reneman, G. Jager, E. J. P. Vlieger, S. D. Olabarriaga, C. Lavini, I. Bisschops, C. B. Majoie, J. Booij, G. J. Den Heeten, and W. Van den Brink. 2007. A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology 32 (2):458. doi:10.1038/sj.npp.1301225.
   Google Scholar
• Dell’Osso, L., R. Dalle Luche, and C. Carmassi. 2015. A new perspective in post- traumatic stress disorder: Which role for unrecognized autism spectrum. International Journal of Emergency Mental Health 17:e188.
   Google Scholar
• Den Hollander, B., M. Schouw, P. Groot, H. Huisman, M. Caan, F. Barkhof, and L. Reneman. 2012. Preliminary evidence of hippocampal damage in chronic users of ecstasy. Journal of Neurology, Neurosurgery, and Psychiatry 83 (1):83–85. doi:10.1136/jnnp.2010.228387.
   PubMed Web of Science ®Google Scholar
• Dunn, D. S., and E. E. Andrews. 2015. Person-first and identity-first language: Developing psychologists’ cultural competence using disability language. American Psychologist 70 (3):255. doi:10.1037/a0038636.
   PubMed Web of Science ®Google Scholar
• Dziobek, I., K. Rogers, S. Fleck, M. Bahnemann, H. R. Heekeren, O. T. Wolf, and A. Convit. 2008. Dissociation of cognitive and emotional empathy in adults with Asperger syndrome using the Multifaceted Empathy Test (MET). Journal of Autism and Developmental Disorders 38 (3):464–73. doi:10.1007/s10803-007-0486-x.
   PubMed Web of Science ®Google Scholar
• Grinspoon, L., and J. B. Bakalar. 1986. Can drugs be used to enhance the psychotherapeutic process? American Journal of Psychotherapy 40 (3):393–404. doi:10.1176/appi.psychotherapy.1986.40.3.393.
   PubMed Web of Science ®Google Scholar
• Guest, G., K. M. MacQueen, and E. E. Namey. 2012. Validity and reliability (credibility and dependability) in qualitative research and data analysis. Applied Thematic Analysis 79–106. London: Sage Publications.
   Google Scholar
• Halpern, J. H., A. R. Sherwood, J. I. Hudson, S. Gruber, D. Kozin, and H. G. Pope Jr. 2011. Residual neurocognitive features of long‐term ecstasy users with minimal exposure to other drugs. Addiction 106 (4):777–86. doi:10.1111/j.1360-0443.2010.03252.x.
   PubMed Web of Science ®Google Scholar
• Halpern, P., J. Moskovich, B. Avrahami, Y. Bentur, D. Soffer, and K. Peleg. 2010. Morbidity associated with MDMA (ecstasy) abuse: A survey of emergency department admissions. Human and Experimental Toxicology 30 (4):259–66. doi:10.1177/0960327110370984.
   PubMed Web of Science ®Google Scholar
• Hoekstra, R. A., M. Bartels, D. C. Cath, and D. I. Boomsma. 2008. Factor structure, reliability and criterion validity of the Autism-Spectrum Quotient (AQ): A study in Dutch population and patient groups. Journal of Autism and Developmental Disorders 38 (8):1555–66. doi:10.1007/s10803-008-0538-x.
   PubMed Web of Science ®Google Scholar
• Johansen, P. Ø., and T. S. Krebs. 2009. How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale. 23 (4):389–91. doi:10.1177/0269881109102787
   Google Scholar
• Joshi, G., J. Wozniak, C. Petty, M. K. Martelon, R. Fried, A. Bolfek, A. Kotte, J. Stevens, S. L. Furtak, M. Bourgeois, and J. Caruso. 2013. Psychiatric comorbidity and functioning in a clinically referred population of adults with autism spectrum disorders: A comparative study. Journal of Autism and Developmental Disorders 43:1314–25. doi:10.1007/s10803-012-1679-5.
   PubMed Web of Science ®Google Scholar
• Mithoefer, M. C., M. T. Wagner, A. T. Mithoefer, L. Jerome, and R. Doblin. 2011. The safety and efficacy of±3, 4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. Journal of Psychopharmacology 25 (4):439–52. doi:10.1177/0269881110378371.
   PubMed Web of Science ®Google Scholar
• Mithoefer, M. C., M. T. Wagner, A. T. Mithoefer, L. Jerome, S. F. Martin, B. Yazar-Klosinski, Y. Michel, T. D. Brewerton, and R. Doblin. 2013. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3, 4-methylenedioxymethamphetamine-assisted psychotherapy: A prospective long-term follow-up study. Journal of Psychopharmacology 27 (1):28–39. doi:10.1177/0269881112456611.
   PubMed Web of Science ®Google Scholar
• Mithoefer, M. C., A. T. Mithoefer, A. A. Feduccia, L. Jerome, M. Wagner, J. Wymer, J. Holland, S. Hamilton, B. Yazar-Klosinski, A. Emerson, and R. Doblin. 2018. 3, 4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: A randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry 5(6):486–97. doi:10.1016/S2215-0366(18)30135-4.
   PubMed Web of Science ®Google Scholar
• Newschaffer, C. J., L. A. Croen, J. Daniels, E. Giarelli, J. K. Grether, S. E. Levy, D. S. Mandell, L. A. Miller, J. Pinto-Martin, J. Reaven, and A. M. Reynolds. 2007. The epidemiology of autism spectrum disorders. Annual Review of Public Health 28:235–58. doi:10.1146/annurev.publhealth.28.021406.144007.
   PubMed Web of Science ®Google Scholar
• Nichols, D. E. 1986. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: Entactogens. Journal of Psychoactive Drugs 18 (4):305–13. doi:10.1080/02791072.1986.10472362.
   PubMed Web of Science ®Google Scholar
• Parrott, A. C. 2007. The psychotherapeutic potential of MDMA (3, 4- methylenedioxymethamphetamine): An evidence-based review. Psychopharmacology 191 (2):181–93. doi:10.1007/s00213-007-0703-5.
   PubMed Web of Science ®Google Scholar
• Ramsay, J. R., E. S. Brodkin, M. R. Cohen, J. Listerud, A. L. Rostain, and E. Ekman. 2005. ‘Better strangers’: Using the relationship in psychotherapy for adult patients with Asperger Syndrome. Psychotherapy: Theory, Research, Practice, Training 42 (4):483. doi:10.1037/0033-3204.42.4.483.
   Web of Science ®Google Scholar
• Riedlinger, J. E. 1985. The scheduling of MDMA: A pharmacist’s perspective. Journal of Psychoactive Drugs 17 (3):167–71. doi:10.1080/02791072.1985.10472337.
   PubMed Web of Science ®Google Scholar
• Schulte-Rüther, M., E. Greimel, M. Piefke, I. Kamp-Becker, H. Remschmidt, G. R. Fink, B. Herpertz-Dahlmann, and K. Konrad. 2013. Age- dependent changes in the neural substrates of empathy in autism spectrum disorder. Social Cognitive and Affective Neuroscience 9 (8):1118–26. doi:10.1093/scan/nst088.
   PubMed Web of Science ®Google Scholar
• Smith, A. 2009. The empathy imbalance hypothesis of autism: A theoretical approach to cognitive and emotional empathy in autistic development. The Psychological Record 59 (3):489–510. doi:10.1007/BF03395675.
   Web of Science ®Google Scholar
• Song, Y., and Y. Hakoda. 2018. Selective impairment of basic emotion recognition in people with Autism: Discrimination thresholds for recognition of facial expressions of varying intensities. Journal of Autism and Developmental Disorders 48 (6):1886–94. doi:10.1007/s10803-017-3428-2.
   PubMed Web of Science ®Google Scholar
• Sumnall, H. R., J. C. Cole, and L. Jerome. 2006. The varieties of ecstatic experience: An exploration of the subjective experiences of ecstasy. Journal of Psychopharmacology 20 (5):670–82. doi:10.1177/0269881106060764.
   PubMed Web of Science ®Google Scholar
• Tsai, L. Y. 2007. Asperger syndrome and medication treatment. Focus on Autism and Other Developmental Disabilities 22 (3):138–48. doi:10.1177/10883576070220030101.
   Google Scholar
• Vannucchi, G., G. Masi, C. Toni, L. Dell’Osso, D. Marazziti, and G. Perugi. 2014. Clinical features, developmental course, and psychiatric comorbidity of adult autism spectrum disorders. CNS Spectrums 19 (2):157–64. doi:10.1017/S1092852913000941.
   PubMed Web of Science ®Google Scholar
• Vizeli, P., and M. E. Liechti. 2017. Safety pharmacology of acute MDMA administration in healthy subjects. Journal of Psychopharmacology 31 (5):576–88. doi:10.1177/0269881117691569.
   PubMed Web of Science ®Google Scholar
• Vollenweider, F. X., A. Gamma, M. Liechti, and T. Huber. 1998. Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naıve healthy volunteers. Neuropsychopharmacology 19 (4):241–51. doi:10.1016/S0893-133X(98)00013-X.
   PubMed Web of Science ®Google Scholar